MarketOpen Podcast

MarketOpen Podcast

di MarketOpen Australia

MarketOpen Podcast Episode 55 - ECS Botanics

In this episode, we sit down with Nan-Maree Schoerie, who serves as the Managing Director of ECS Botanics (ASX:ECS). Join us as we delve into the most recent developments and valuable insights within ECS, and take a closer look at what drives Nan-Maree's success. Nan-Maree (Nan) has held Australian business leader positions of large organisations such as GE; ThermoFisher and Ventia. A common thread through all her tenures was her ability to deliver extraordinary bottom and top line growth across different geographies and industries. Nan’s passion for delivering customer value and her determination to deliver outcomes resulted in enviable customer retention rates whilst regularly securing large annuity contracts, some valued at over $200m. Nan founded Murray Meds prior to be acquired by ECS in March 2021. On acquisition Murray Meds was one of the largest and most advanced EU GMP compliant medicinal cannabis companies in Australia.

MarketOpen Podcast Episode 54 - Capral

In this episode, we sit down with Tony Dragicevich, who serves as the Chief Executive Officer and Managing Director of Capral (ASX:CAA). Join us as we delve into the most recent developments and valuable insights within CAA, and take a closer look at what drives Tony's success. Mr Dragicevich joined Capral in January 2013 and became the Managing Director and Chief Executive Officer on 15 April 2013. Mr Dragicevich is an experienced CEO and business leader who has been involved in the improvement of a number of businesses, having previously served as Managing Director of the Wattyl Group, and as Chief Executive of GWA Bathroom and Fittings, Managing Director of the Red Paper Group and General Manager of Tasman Insulation.

MarketOpen Podcast Episode 53 - Cavalier Resources

In this episode, we sit down with Daniel Tuffin, who serves as the Executive Technical Director of Cavalier Resources (ASX:CVR). Join us as we delve into the most recent developments and valuable insights within CVR, and take a closer look at what drives Daniel's success. Co-founder and MD of successful mine consulting firm Auralia Mining Consulting, Daniel is a hands-on mining engineer with over 20 years’ experience. His career began in iron ore and gold projects in WA and later extended internationally. While acting as a consultant he has carried out many technical studies and has signed off on Ore Reserves on the ASX, LSE and TSX. He’s since established many successful companies and mining projects, including co-founding private Kalgoorlie gold mining venture Rose Dam Resources which to date has produced over 30koz of gold. Daniel has a wealth of experience specific to the Company; he has in been involved in prior development of the Crawford and Gambier Lass North Projects around Leonora and carried out various mine planning work on the Golden Cities Project north of Kalgoorlie. Daniel holds a BEng (Mining), BSc (Mine and Engineering Surveying), a Diploma in Project Management and is a Fellow of the AusIMM and accredited Chartered Professional and a Member of the AICD having completed their Directors Course. Daniel is currently a director of ASX listed companies Panther Metals Limited (ASX:PNT) and Mt Malcolm Mines NL (ASX:M2M).

MarketOpen Podcast Episode 52 - Argenica Therapeutics

In this episode, we sit down with Dr Liz Dallimore, who serves as the Chief Executive Officer and Managing Director of Argenica Therapeutics (ASX:AGN). Join us as we delve into the most recent developments and valuable insights within AGN, and take a closer look at what drives Liz's success. Dr Dallimore has over 20 years’ experience in both biotechnology and management consulting across Australia and the UK. She has held senior roles in management consulting as KPMG’s Australian Director of Research Engagement and Commercialisation, structuring technology commercialisation deals across a range of sectors, with a specific focus on biotechnology. Prior to this Liz held senior management roles with Ernst & Young and PricewaterhouseCoopers in technology advisory and R&D. Prior to moving into management consulting, Liz was a research scientist at the Australian Neuromuscular Research Institute (now the Perron Institute of Neurological & Translational Sciences) and the UK’s Food Standard’s Agency. Dr Dallimore is also a Non-Executive director of the Chamber of Commerce and Industry WA and AusBiotech, as well as and Industry Advisor to the Telethon Kids Institute’s Innovation and Commercialisation Committee and member of the Stan Perron Charitable Foundation’s Health Research Advisory Panel advising on child health research funding. Dr Dallimore holds a PhD in Neuroscience jointly completed at Oxford University and the University of Western Australia, an MBA from the Australian Graduate School of Management, and is a Member of the Australian Institute of Company Directors.

MarketOpen Podcast Episode 51 - ClearVue

In this episode, we sit down with Martin Deil, who serves as the Chief Executive Officer of ClearVue (ASX:CPV). Join us as we delve into the most recent developments and valuable insights within CPV, and take a closer look at what drives Martin's success. Martin Deil has built up a lot of beautiful things across an international career in the face of building design. And less than a year into the job as CEO of ClearVue, he is now building up something greater than aesthetics, bringing both renewable clarity and architectural grace with the company’s solar powered technology.

MarketOpen Podcast Episode 50 - Archer Materials

In this episode, we sit down with Dr Mohammad Choucair, who serves as the Chief Executive Officer of Archer Materials (ASX:AXE). Join us as we delve into the most recent developments and valuable insights within AXE, and take a closer look at what drives Mohammad's success. Dr Mohammad Choucair was appointed Chief Executive Officer on 1st December 2017. Dr Choucair has a strong technical background in nanotechnology, and has spent the last decade implementing governance, control and key compliance requirements for the creation and commercial development of innovative technologies with global impact. Dr Choucair served a 2-year mandate on the World Economic Forum Global Council for Advanced Materials and is a Fellow of both The Royal Society of New South Wales and The Royal Australian Chemical Institute. He has a strong record of delivering innovation and has been recognised internationally as a forward thinker.

MarketOpen Podcast Episode 49 - Voltaic Strategic Resources

In this episode, we sit down with Michael Walshe, who serves as the Chief Executive Officer of Voltaic Strategic Resources (ASX:VSR). Join us as we delve into the most recent developments and valuable insights within VSR, and take a closer look at what drives Michael's success. Mr. Walshe has over 15 years of international experience in engineering, operations, technology commercialisation, and project development roles across the minerals, chemicals, and renewable energy sectors. Michael joins Voltaic after a 10 year career at Metso:Outotec where positions included Director and Vice President roles for the Asia Pacific Minerals business, in addition to being a member of the executive management team. His experience covers team leadership, metallurgy, process design, sales, and structuring project finance packages for junior miners via export credit funding. Michael has been involved in several international minerals projects with particular exposure to Asian countries such as Indonesia, the Philippines, PNG and South Korea, and has worked across a wide range of commodities including lithium, rare earths, nickel, copper, zinc and gold. Michael holds a Bachelor of Chemical and Process Engineering (Hons.) from University College Dublin, Ireland, and a Master of Business Administration (Finance) from the Australian Institute of Business. He is a chartered engineer with both Engineers Australia & the Institution of Chemical Engineers (IChemE), and is a member of the Australasian Institute of Mining & Metallurgy (AusIMM).

MarketOpen Podcast Episode 48 - Immuron

In this episode, we sit down with Steven Lydeamore, who serves as the Chief Executive Officer and Jerry Kanellos, who serves as Chief Operating Officer of Immuron (ASX:IMC). Join us as we delve into the most recent developments and valuable insights within IMC, and take a closer look at what drives Steven and Jerry's success. Mr. Lydeamore has 30 years international pharmaceutical experience, working in Australia, Canada and USA. Mr. Lydeamore brings valuable international experience having spent eleven years working at Canadian global pharmaceutical company Apotex Inc., and four years for Mayne Pharma (USA) Limited. This includes valuable experience in mergers and acquisitions, finance, business development, sales and marketing, manufacturing, and research and development. Mr. Lydeamore was most recently Chief Executive Officer (CEO) of Anatara Lifesciences Limited (ASX:ANR), during which time the company successfully transitioned from a preclinical to a clinical company following development of a gastrointestinal tract delivery technology from which two products have commenced human clinical trials. Dr Jerry Kanellos has over twenty years’ experience in the pharmaceutical and biotechnology industry, and has held leadership roles in business development, project management, intellectual property portfolio management, research and development and senior management, and holds a PhD in medicine from the University of Melbourne. Dr Kanellos has worked as a consultant to the biotechnology industry and has provided development and commercialisation strategies for various bodies including academic institutes, private and publicly listed companies, and government departments. He has also been involved in the establishment and management of several startup biotechnology companies. During his ten years tenure in research and development at CSL Limited, Dr Kanellos gained considerable experience in the drug development process, formulation development through to pharmaceutical scale up and cGMP manufacture successfully leading the Chemistry Manufacturing and Controls (CMC) programs for the approval, manufacture and launch of several products.

MarketOpen Podcast Episode 47 - Viking Mines

In this episode, we sit down with Julian Woodcock, who serves as the Managing Director of Viking Mines (ASX:VKA). Join us as we delve into the most recent developments and valuable insights within VKA, and take a closer look at what drives Julian's success. Mr. Woodcock holds both a Bachelor of Science (Geology) from the University of Manchester (UK) and a Master of Science (Mining Geology) from the Camborne School of Mines (UK). Mr. Woodcock is also a Chartered Professional geologist with the AusIMM and a Fellow of the Geological Society of London. His career spans 2 decades in the exploration and production of various commodities across multiple counties.Previous engagements include Senior Management roles with Kinross Gold (NYSE:KGC), Gold Fields (NYSE:GFI), Evolution Mining (ASX:EVN) and Gold Road Resources (ASX:GOR). Experience ranges from international open pit and underground production geology roles through to a decade working as Exploration Manager in the WA Goldfields, leading large exploration teams with multi million-dollar budgets taking exploration projects from discovery through to development.Notable accomplishments involve significant gold discoveries and resource ounce growth including the +2Moz Invincible Deposit at St Ives which advanced from discovery drillhole to production in <3 years, the 0.3Moz Gilmour deposit at Yamarna defined in <12 months and +1Moz resource conversion at Gruyere. Mr. Woodcock brings a significant amount of technical and operational experience to Viking Mines in the exploration and development of resource projects.

MarketOpen Podcast Episode 46 - Australian Rare Earths

In this episode, we sit down with Travis Beinke, who serves as the CEO of Australian Rare Earths (ASX:AR3). Join us as we delve into the most recent developments and valuable insights within AR3, and take a closer look at what drives Travis' success. Travis Beinke is a highly experienced executive with more than 20 years’ experience in the resources sector with both Australian and international listed companies.  Travis has a broad range of strategic, commercial, finance and business development skills, particularly in exploration and growth projects. Travis has spent the last 5 years with OZ Minerals, initially holding the role of Group Manager Commercial, prior to leading the company’s engagement with equity markets. 

13 di 18